Ultrasonography for Nutritional Assesment in Cirrhotic Patients
Launched by NATIONAL LIVER INSTITUTE, EGYPT · Sep 20, 2019
Trial Information
Current as of June 24, 2025
Unknown status
Keywords
ClinConnect Summary
in the study, the investigator will use ultrasound to assess the nutritional state of cirrhotic patients after major abdominal surgery,The investigator aim to assess reliability of ultrasound as a bedside,non invasive tool,The investigator will enroll 72 patients for or study which is an observational study
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • hepatic patients classified as child A, B undergoing major abdominal surgery (liver resection,whipple,Splenectomy,colectomy, Common Bile Duct exploration,By pass surgery)
- • 18-60 yrs old
- • no past history of nutritional problems,chronic use of drugs,patients with no orthopedic issues such as skeletal fractures or immobilization
- Exclusion Criteria:
- • Refusal of the patient to share in the study, relevant comorbidities (renal, heart disease or COPD)
- • previous immune abnormalities including treatment with corticosteroids
- • neuromuscular diseases
- • laparoscopic surgery
- • patients on parenteral nutrition
About National Liver Institute, Egypt
The National Liver Institute (NLI) in Egypt is a leading research and clinical institution dedicated to advancing the understanding and treatment of liver diseases. Renowned for its commitment to excellence in hepatology, the NLI conducts innovative clinical trials aimed at evaluating new therapies and improving patient outcomes. With a multidisciplinary team of experts, state-of-the-art facilities, and a strong focus on translational research, the institute plays a pivotal role in shaping liver health policies and enhancing clinical practices in the region. By fostering collaboration with international research entities, the National Liver Institute is at the forefront of liver disease research and education in Egypt and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shibīn Al Kawm, Menoufia, Egypt
Patients applied
Trial Officials
Amany A. Zayd, MBBCH
Principal Investigator
Department of Anesthesia NLI
Eman S. Ibrahim, MD
Study Director
National Liver Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials